Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

NCT04205864 is registered in ClinicalTrials.gov with Kocaeli University as lead sponsor.

NCT NCT04205864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04205864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.
Lead sponsor
Kocaeli University
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2019
Completion date
July 2, 2020
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrium cancer, lymphocele, lymphocele after surgical procedure